These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21245333)

  • 1. Killer cell Ig-like receptor (KIR) 3DL1 down-regulation enhances inhibition of type 1 diabetes by autoantigen-specific regulatory T cells.
    Qin H; Wang Z; Du W; Lee WH; Wu X; Riggs AD; Liu CP
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):2016-21. PubMed ID: 21245333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
    Manirarora JN; Wei CH
    J Immunol; 2015 Dec; 195(11):5203-14. PubMed ID: 26482409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells.
    Brode S; Raine T; Zaccone P; Cooke A
    J Immunol; 2006 Nov; 177(10):6603-12. PubMed ID: 17082572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells.
    Wang D; Qin H; Du W; Shen YW; Lee WH; Riggs AD; Liu CP
    Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9493-8. PubMed ID: 22645357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KLRG1 expression identifies short-lived Foxp3
    Kornete M; Mason E; Istomine R; Piccirillo CA
    Autoimmunity; 2017 Sep; 50(6):354-362. PubMed ID: 28850267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen Therapy Delays Autoimmune Diabetes and Promotes the Protective Efficiency of Natural Killer T-Cell Activation in Female Nonobese Diabetic Mice.
    Gourdy P; Bourgeois EA; Levescot A; Pham L; Riant E; Ahui ML; Damotte D; Gombert JM; Bayard F; Ohlsson C; Arnal JF; Herbelin A
    Endocrinology; 2016 Jan; 157(1):258-67. PubMed ID: 26485613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of New Onset Type 1 Diabetes by Oral
    Mbongue JC; Rawson J; Garcia PA; Gonzalez N; Cobb J; Kandeel F; Ferreri K; Husseiny MI
    Front Immunol; 2019; 10():320. PubMed ID: 30863412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes.
    Gregg RK; Jain R; Schoenleber SJ; Divekar R; Bell JJ; Lee HH; Yu P; Zaghouani H
    J Immunol; 2004 Dec; 173(12):7308-16. PubMed ID: 15585854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
    Chen C; Lee WH; Yun P; Snow P; Liu CP
    J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory function of a novel population of mouse autoantigen-specific Foxp3 regulatory T cells depends on IFN-gamma, NO, and contact with target cells.
    Chen C; Liu CP
    PLoS One; 2009 Nov; 4(11):e7863. PubMed ID: 19924236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDC12-4.1 T-cell receptor transgenic insulin-specific CD4 T cells are resistant to in vitro differentiation into functional Foxp3+ T regulatory cells.
    Sarikonda G; Fousteri G; Sachithanantham S; Miller JF; Dave A; Juntti T; Coppieters KT; von Herrath M
    PLoS One; 2014; 9(11):e112242. PubMed ID: 25393309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.
    Ly D; Mi QS; Hussain S; Delovitch TL
    J Immunol; 2006 Sep; 177(6):3695-704. PubMed ID: 16951329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Diabetogenic Immunity by IL-15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.
    Stocks BT; Wilson CS; Marshall AF; Hoopes EM; Moore DJ
    J Immunol; 2019 Jul; 203(1):158-166. PubMed ID: 31127035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining anti-IL-7Rα antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.
    Vazquez-Mateo C; Collins J; Goldberg SJ; Lawson M; Hernandez-Escalante J; Dooms H
    PLoS One; 2019; 14(3):e0214379. PubMed ID: 30908554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-derived suppressor cells prevent type 1 diabetes in murine models.
    Yin B; Ma G; Yen CY; Zhou Z; Wang GX; Divino CM; Casares S; Chen SH; Yang WC; Pan PY
    J Immunol; 2010 Nov; 185(10):5828-34. PubMed ID: 20956337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.
    Liu X; Zhang S; Li X; Zheng P; Hu F; Zhou Z
    Diabetes Metab Res Rev; 2016 Sep; 32(6):522-33. PubMed ID: 26797873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.
    Mattner J; Mohammed JP; Fusakio ME; Giessler C; Hackstein CP; Opoka R; Wrage M; Schey R; Clark J; Fraser HI; Rainbow DB; Wicker LS
    PLoS Genet; 2019 Jun; 15(6):e1008178. PubMed ID: 31199784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
    Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
    Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.